RBC Capital Downgrades Alpine Immune Sciences (ALPN) to Sector Perform Apr 11, 2024 04:39AM
Alpine Immune Sciences (ALPN) Prices $150M Share and Warrant Offering at $12.50/sh Nov 7, 2023 04:38AM
Alpine Immune Sciences Announces Pricing of $150 Million Public Offering Nov 6, 2023 09:41PM
Alpine Immune Sciences (ALPN) to offer $150M in common stock Nov 6, 2023 06:00AM
Alpine Immune Sciences Announces Proposed Public Offering Nov 6, 2023 06:00AM


Oct 5, 2023 06:24AM RBC Capital Starts Alpine Immune Sciences (ALPN) at Outperform, "Povetacicept could be competitively positioned"
Jun 18, 2020 09:26AM Pre-Open Stock Movers 06/18: (ALPN) (AEMD) (ELOX) Higher; (LPTX) (QUIK) (BIIB) Lower (more...)